Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ovid Therapeutics Inc (NQ: OVID )

3.042 USD +0.092 (+3.11%)
Streaming Delayed Price Updated: 10:58 AM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ovid Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Penny Stocks To Buy According To These Top Analysts Right Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Notable Tuesday Option Activity: RGS, T, OVID
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Regis Corp (RGS), where a total of 3,095 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
First Week of OVID March 19th Options Trading
Investors in Ovid Therapeutics Inc (OVID) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OVID... 
Tags Stocks
From Market News Video
Look Under The Hood: IBB Has 19% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Interesting OVID Put And Call Options For February 2021
Investors in Ovid Therapeutics Inc (OVID) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OVID... 
Tags Stocks
From Market News Video
Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index
From GlobeNewswire News Releases
How The Pieces Add Up: FDM Targets $56
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SNDX CRTX XENE
From Benzinga
70 Biggest Movers From Yesterday
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 150% to close at $5.25 on Thursday after gaining 7% on ... 
Tags Movers WETF SNOW
From Benzinga
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 150% to $5.25 after gaining 7% on Wednesday. The company ... 
Tags ITRM REV MEDS
From Benzinga
62 Biggest Movers From Yesterday
Gainers Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 59.1% to close at $6.49 on Wednesday. Merrimack ... 
Tags IDRA BB Movers
From Benzinga
Mid-Afternoon Market Update: Dow Edges Higher; Sequential Brands Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 0.08% to 29,846.44 while the NASDAQ fell 0.09% to 12,343.79. The S&P also ... 
Tags Intraday Update Market News PFE
From Benzinga
12 Healthcare Stocks Moving In Wednesday's Intraday Session
Gainers NanoVibronix (NASDAQ:NAOV) stock moved upwards by 103.13% to $1.44 during Wednesday's regular session. ... 
Tags Markets Market News healthcare stocks
From Benzinga
Mid-Day Market Update: Crude Oil Rises 3%; Ovid Therapeutics Shares Plummet
Midway through trading Wednesday, the Dow traded down 0.05% to 29,809.24 while the NASDAQ fell 0.11% to 12,341.07. The S&P also ... 
Tags QEP Intraday Update Markets
From Benzinga
56 Stocks Moving In Wednesday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 99% to $1.4111after the company announced "positive" ... 
Tags Market News NTAP STTK
From Benzinga
Why Ovid Therapeutics Stock Is Imploding Today
The company reported disappointing results from a late-stage clinical trial. 
Tags OVID Market News
From Motley Fool
Mid-Morning Market Update: Markets Open Lower; Pfizer's Covid-19 Vaccine Gets UK Approval
Following the market opening Wednesday, the Dow traded down 0.26% to 29,746.26 while the NASDAQ fell 0.45% to 12,298.62. The S&P ... 
Tags Intraday Update QEP Markets
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 2, 2020
Upgrades According to MoffettNathanson, the prior rating for Verizon Communications Inc (NYSE: VZ) was changed from Neutral to ... 
Tags Intraday Update PRG CRSR
From Benzinga
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers NanoVibronix (NASDAQ:NAOV) shares increased by 79.15% to $1.27 during Wednesday's pre-market session. The ... 
Tags MDGS CBIO IRTC
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BNR BEAT ALNA
From Benzinga
41 Stocks Moving in Wednesday's Pre-Market Session
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 65.1% to $0.6770 in pre-market trading. Tredegar Corporation (NYSE: TG) rose 35.2% to ... 
Tags WKHS Trading Ideas CRM
From Benzinga
Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint
From GlobeNewswire News Releases
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
Biotech stocks had a rather uneventful week, as the sector was seen mostly flatlining amid light trading volume ahead of the ... 
Tags BYSI AUTL BNTX
From Benzinga
Investors Grab OVID 25.0% Cheaper Than Its Secondary Stock Offering
Looking back to 92 days ago, Ovid Therapeutics Inc (OVID) priced a 6,250,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
Ovid Therapeutics to Present at the American Epilepsy Society (AES) 2020 Virtual Congress
Abstracts will be presented from the TAK-935/OV935 (soticlestat) clinical development program in Dravet syndrome or Lennox-Gastaut syndrome (Phase 2 ELEKTRA study) and OV101 (gaboxadol) clinical... 
From GlobeNewswire News Releases
Noteworthy Thursday Option Activity: OLED, OVID, LHCG
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Universal Display Corp (OLED), where a total volume of 2,283 contracts has been... 
Tags Stocks
From Market News Video
65 Biggest Movers From Friday
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares jumped 93.5% to close at $16.02 on Friday after the company late Thursday ... 
Tags NCTY GFF AHPI
From Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant ... 
Tags PDD EH SOL
From Benzinga
Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Noteworthy Monday Option Activity: SABR, BJ, OVID
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sabre Corp (SABR), where a total of 98,938 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.